Emerging therapeutic opportunities for psychedelic and related drugs

[thumbnail of Editorial proof.pdf]
Text
- Accepted Version
· Restricted to Repository staff only
· The Copyright of this document has not been checked yet. This may affect its availability.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Wonnacott, S., Stephens, G. J. ORCID: https://orcid.org/0000-0002-8966-4238 and Sharp, T. (2026) Emerging therapeutic opportunities for psychedelic and related drugs. British Journal of Pharmacology. ISSN 1476-5381 doi: 10.1111/bph.70485

Abstract/Summary

Increasing interest in psychedelic and related drugs as potential therapies for a wide spectrum of difficult-to-treat conditions that extend beyond neuropsychiatric disorders provided the impetus for this themed issue. This collection of reviews and original articles includes the mechanistic basis of how these drugs act, the current status of preclinical research and progress in clinical trials, and insight into the regulatory processes that determine clinical approval. In this editorial, we introduce these aspects and provide an overview of current controversies and challenges in the field, as well as highlight the exciting potential that these drugs offer.

Altmetric Badge

Dimensions Badge

Item Type Article
URI https://centaur.reading.ac.uk/id/eprint/130717
Identification Number/DOI 10.1111/bph.70485
Refereed Yes
Divisions Interdisciplinary Research Centres (IDRCs) > Centre for Integrative Neuroscience and Neurodynamics (CINN)
Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Division of Pharmacology
Publisher Wiley
Download/View statistics View download statistics for this item

University Staff: Request a correction | Centaur Editors: Update this record